← All diseases Cancer

Head and neck cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (190)Meta-analysis (53)Treatment guideline (2)Randomized trial (75)Systematic review (50)Phase 3 study (10)Clinical trial (699)Review article (240)Early study (phase 1 or 2) (48)Case report (186)Laboratory or animal study (46)Commentary or editorial (58)Retracted publication (3) Studies currently recruiting (52)

Filter

Publications and studies (3151)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary cutaneous epithelioid hemangioendothelioma of the temporal region: a case report. (2026/12/17) ♡
• Evaluation of the efficacy of microwave ablation therapy for benign thyroid nodules of different compositions. (2026/12/01) ♡
• Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China. (2026/12/01) ♡
• Understanding the benefits of art therapy for cancer-related pain: a call for action. (2026/12/01) ♡
• Cost-effectiveness of pembrolizumab as neoadjuvant therapy and in combination with standard of care (SOC) as adjuvant therapy for stage III-IVA resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC) in Switzerland. (2026/12/01) ♡
• Targeting lipoprotein lipase-positive macrophage-driven GDF-15 expression alleviates cancer cachexia in obese head and neck squamous cell carcinoma. (2026/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Integrating BIA-derived body composition parameters with GLIM criteria for survival prediction in patients with solid tumors. (2026/10/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic Value of the Haemoglobin-Albumin-Lymphocyte-Platelet Score in Head and Neck Cancer: A Systematic Review and Meta-Analysis. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Identifying markers of cachexia and nutritional deficit on radical radiotherapy outcomes in lung and head and neck cancer. (2026/09/01) ♡
• Polyphyllin II inhibits thyroid cancer progression by targeting HRH1 and suppressing Wnt/β‑catenin signaling. (2026/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sialadenoma papilliferum of the floor of the mouth with HPV Positivity: a rare case report and literature review. (2026/08/11) ♡
• Barriers and Facilitators to Evidence-Based Oral Care in Head and Neck Cancer: A Mixed-Methods Study. (2026/08/11) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Response to rethinking thyroid dysfunction after proton and photon radiotherapy for head and neck cancer. (2026/08/10) ♡
• Retraction notice to "LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation" [Cellular Signalling 77 (2021) 109808]. (2026/08/10) ♡
• Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy. (2026/08/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Repair of a thoracic incisional hernia in a patient after elective abdominothoracic esophageal resection. (2026/08/10) ♡
• Biomarkers Correlating With the Development of Oral Squamous Cell Carcinoma From Leukoplakia. (2026/08/10) ♡
• Establishing a genetic mutation panel for predicting malignant transformation of oral leukoplakia: A prospective cohort study. (2026/08/10) ♡
• Management trends and mortality risk of oral cavity severe dysplasia/carcinoma in situ. (2026/08/10) ♡
• The G-quadruplex ligand CX-5461 inhibits laryngeal cancer via inducing immunogenic cell death and remodeling the tumor immune microenvironment. (2026/08/10) ♡
• SDHC c.397C>T-Related Pheochromocytomas and Paragangliomas: Insights from an International Study. (2026/08/10) ♡
• Radiological Late Dental Adverse Effects Following Treatment for Paediatric Head and Neck Rhabdomyosarcoma: Results of a Transatlantic Multicentre Cohort Study. (2026/08/10) ♡
• Impact of biopsy-related variables on MRI assessment of tumor invasion in early oral squamous cell carcinoma. (2026/08/10) ♡
• NAT10-mediated ac(4)C acetylation of PKM2 promotes papillary thyroid carcinoma through regulating glycolysis. (2026/08/10) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Circulating microRNAs: a new era in early detection of oral squamous cell carcinoma (OSCC) - a systematic review and meta-analysis. (2026/08/10) ♡
• Socioeconomic factors associated with post-operative biochemical remission in acromegaly. (2026/08/10) ♡
• Incidental detection of cancers during population-based endoscopic gastric cancer screening in Japan. (2026/08/10) ♡
• A dual role for miR-210-3p in hypoxia-driven signaling and mitotic regulation in cancer. (2026/08/10) ♡
• A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately. (2026/08/10) ♡
• Healing Following Endoscopic Reconstruction of the Anterior Skull Base in Patients With Sinonasal Malignancies. (2026/08/09) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Trans-Submental Endoscopic Thyroidectomy: Methodological Considerations and Implications for Outcome Reporting. (2026/08/09) ♡
• Survival Outcomes and Prognostic Factors of Primary Salivary Gland Malignancy: A 24-Year Retrospective Cohort Study. (2026/08/09) ♡
• Distress level in newly diagnosed thyroid cancer patients and predictors of clinically significant distress. (2026/08/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimal timing of post-therapeutic [(131)I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review. (2026/08/08) ♡
• Radiation Therapy and Overall Survival in Perineural Invasion-Positive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis. (2026/08/08) ♡
• Determinants of physicians' risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer. (2026/08/08) ♡
• Deciphering the immune landscape of parathyroid carcinoma: implications for immunotherapeutic responsiveness. (2026/08/08) ♡
• mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment. (2026/08/08) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Metastatic site combinations define distinct prognostic groups in metastatic major salivary gland adenoid cystic carcinoma. (2026/08/08) ♡
• Corrigendum to "Buyang huanwu decoction (BYHWD) attenuates sepsis-induced myocardial injury by suppressing aberrant iron accumulation in preclinical mouse models" [Phytomedicine, 141, 2025, 156689]. (2026/08/08) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Response to: Comment on "Association of Lead in Drinking Water With Head and Neck Cancer in the United States". (2026/08/07) ♡
• Cost-Utility Analysis of Sentinel Node Biopsy Versus Selective Neck Dissection for Node-Negative Early-Stage Oral Cancers: A Health Economic Evaluation from the Indian Healthcare System Perspective. (2026/08/07) ♡
• Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy. (2026/08/07) ♡
• Surgical management of facial nerve schwannomas: a contemporary series of 67 surgeries. (2026/08/07) ♡
• Radiation-induced oral mucositis: Correlation between clinician-assessed WHO grades and patient-reported outcomes, an exploratory prospective observational pilot study. (2026/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. De-escalation of radiotherapy in HPV-negative non-nasopharyngeal head and neck squamous cell carcinoma: a systematic review. (2026/08/07) ♡
• Adjuvant radiation for major salivary gland adenoid cystic carcinoma in the modern era: updated patterns of care and survival from the National Cancer Database (2004-2021). (2026/08/07) ♡
• Tumor-derived extracellular vesicles-mediated oxidative stress transfer activates glycometabolic reprogramming of CAFs. (2026/08/07) ♡
• Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy. (2026/08/07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol. (2026/08/07) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.